Eli Lilly delivered a standout performance in the third quarter of 2025, surpassing analysts’ expectations across revenue and earnings. The…
Read More

Eli Lilly delivered a standout performance in the third quarter of 2025, surpassing analysts’ expectations across revenue and earnings. The…
Read More
Medical researchers have formally recognized a distinctive form of diabetes tied to malnutrition and atypical symptoms. For years, cases that…
Read More
September 2025 — A startling new global study reveals that 44 percent of people aged 15 and older with diabetes…
Read More